Wegovy's revenue jumped by 86% year over year to 58.2 billion DKK ($8.1 billion). It's no wonder Novo Nordisk's shares jumped following the release of its fourth-quarter and full-year 2024 ...

Life Kit is here to help you get it together. Want another life hack? Try Life Kit+. You'll support the show and unlock exclusive curated playlists and sponsor-free listening. Learn more at plus ...

Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 diabetes and Wegovy for obesity, but is coming under competitive pressure ...

while Wegovy rocketed 79% to $2.5 billion. The breakneck pace of growth with the two drugs has helped to catapult Novo Nordisk's valuation to $289 billion, making it one of Europe's most valuable ...

Nintendo Switch 2 is finally confirmed. After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next-generation ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...